Seong H. Kim - Search Results

Year	Number of Results
1973	1
1996	1
2002	17
2003	10
2004	15
2005	24
2006	34
2007	46
2008	48
2009	75
2010	75
2011	68
2012	91
2013	89
2014	91
2015	102
2016	108
2017	94
2018	94
2019	101
2020	104
2021	101
2022	80
2023	98
2024	33

1

The Effect of Nutrition Intervention with Oral Nutritional Supplements on Pancreatic and Bile Duct Cancer Patients Undergoing Chemotherapy.

Kim SH, Lee SM, Jeung HC, Lee IJ, Park JS, Song M, Lee DK, Lee SM. Kim SH, et al. Nutrients. 2019 May 22;11(5):1145. doi: 10.3390/nu11051145. Nutrients. 2019. PMID: 31121926 Free PMC article. Clinical Trial.

2

The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.

Ariceta G, Dixon BP, Kim SH, Kapur G, Mauch T, Ortiz S, Vallee M, Denker AE, Kang HG, Greenbaum LA; 312 Study Group. Ariceta G, et al. Kidney Int. 2021 Jul;100(1):225-237. doi: 10.1016/j.kint.2020.10.046. Epub 2020 Dec 8. Kidney Int. 2021. PMID: 33307104 Free article. Clinical Trial.

3

Inhibition of BRD4 Promotes Pexophagy by Increasing ROS and ATM Activation.

Kim YH, Jo DS, Park NY, Bae JE, Kim JB, Lee HJ, Kim SH, Kim SH, Lee S, Son M, Park K, Jeong K, Yeom E, Cho DH. Kim YH, et al. Cells. 2022 Sep 12;11(18):2839. doi: 10.3390/cells11182839. Cells. 2022. PMID: 36139416 Free PMC article.

4

Editorial: Advances in Tribochemistry.

Chen L, Rosenkranz A, Rapoport LS, Kim SH. Chen L, et al. Among authors: kim sh. Front Chem. 2022 Jun 6;10:925015. doi: 10.3389/fchem.2022.925015. eCollection 2022. Front Chem. 2022. PMID: 35734445 Free PMC article. No abstract available.

5

A selective ER-phagy exerts neuroprotective effects via modulation of α-synuclein clearance in parkinsonian models.

Kim DY, Shin JY, Lee JE, Kim HN, Chung SJ, Yoo HS, Kim SJ, Cho HJ, Lee EJ, Nam SJ, Kim SH, Jang J, Lee SE, Lee PH. Kim DY, et al. Proc Natl Acad Sci U S A. 2023 Sep 12;120(37):e2221929120. doi: 10.1073/pnas.2221929120. Epub 2023 Sep 5. Proc Natl Acad Sci U S A. 2023. PMID: 37669380 Free PMC article.

6

Linderae Radix Ameliorates Cognitive Dysfunction by Inhibiting Neuroinflammation and Synaptic Damage in Alzheimer's Disease Models.

Kim SH, Ju IG, Kim JH, Eo H, Son SR, Jang DS, Oh MS. Kim SH, et al. Mol Neurobiol. 2023 Dec;60(12):7196-7207. doi: 10.1007/s12035-023-03544-z. Epub 2023 Aug 5. Mol Neurobiol. 2023. PMID: 37542650

7

Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial.

Cho EJ, Kim MH, Kim YH, Chang K, Choi DJ, Kang WC, Shin J, Kim SH, Lee N, Son JW, Doh JH, Kim WS, Hong SJ, Rhee MY, Ahn Y, Lim SW, Hong SP, Choi SY, Hyon MS, Hwang JY, Kwon K, Cha KS, Ihm SH, Lee JH, Yoo BS, Kim HS. Cho EJ, et al. J Clin Hypertens (Greenwich). 2023 Sep;25(9):817-827. doi: 10.1111/jch.14707. Epub 2023 Aug 23. J Clin Hypertens (Greenwich). 2023. PMID: 37614053 Free PMC article. Clinical Trial.

8

Protective effects of an electrophilic metabolite of docosahexaenoic acid on UVB-induced oxidative cell death, dermatitis, and carcinogenesis.

Kim SH, Lee SE, Kim SJ, Fang X, Hur J, Sozen E, Özer NK, Kim KP, Surh YJ. Kim SH, et al. Redox Biol. 2023 Jun;62:102666. doi: 10.1016/j.redox.2023.102666. Epub 2023 Mar 9. Redox Biol. 2023. PMID: 36934646 Free PMC article.

9

Effectiveness of low-intensity atorvastatin 5 mg and ezetimibe 10 mg combination therapy compared with moderate-intensity atorvastatin 10 mg monotherapy: A randomized, double-blinded, multi-center, phase III study.

Lee SA, Hong SJ, Sung JH, Kim KS, Kim SH, Cho JM, Chun SW, Lee SR, Kim CS, Kim TN, Kim DH, Park HC, Kim BJ, Kim HS, Choi JY, Hong YJ, Chung JW, Yoon SB, Lee SH, Lee CW. Lee SA, et al. Medicine (Baltimore). 2023 Nov 24;102(47):e36122. doi: 10.1097/MD.0000000000036122. Medicine (Baltimore). 2023. PMID: 38013289 Free PMC article. Clinical Trial.

10

CCL20 inhibition for treating inflammation in ankylosing spondylitis.

Won EJ, Kim HJ, Lee YJ, Kim MJ, Lee HI, Jang HH, Kim SH, Kang JH, Park KJ, Shim SC, Jo S, Kim TH, Kim TJ. Won EJ, et al. Rheumatology (Oxford). 2023 Dec 1;62(12):4000-4005. doi: 10.1093/rheumatology/kead268. Rheumatology (Oxford). 2023. PMID: 37279731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

1,406 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

1,406 results

Results by year